ARCHIVES

FDA Approves Cyramza for Stomach Cancer; Zykadia in NSCLC; Lipiodol for HCC Imaging; And Cobas HPV Test for Primary Screening

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

Congressional Report Says NCI Ignored Das, Procedure, In Charges To Screening Guidelines

November 4, 1994

Democrats Say Bush Budget Neglects NSF And NASA.

March 23, 2001

Supporters And A Critic Of Burzynski Comment

October 30, 1998

Obey Questions NCI honesty, Transfers IARC Monograph Support To NIH

October 15, 1982

Two Phase II Studies of Ibrutinib Deliver High Response Rates

December 27, 2013

NCI Begins Large National Clinical Trial To Validate Biomarker For Lung Cancer

October 31, 2008